Hip resurfacing device shows promise in arthritis patients

NCT ID NCT00611585

Completed Disease control Sponsor: Smith & Nephew, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at the long-term safety and effectiveness of the Birmingham Hip Resurfacing System, a metal hip implant, in 329 adults with arthritis. The main goal was to see how many patients needed a revision (replacement or removal) within 10 years. The study also measured hip function and pain using the Harris Hip Score. Results help confirm the device's performance in real-world use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Birmingham Hip Resurfacing System (a metal-on-metal hip implant device)
What this could lead to: If successful, this could confirm that the Birmingham Hip Resurfacing System is a safe and effective long-term option for hip arthritis, potentially delaying or avoiding the need for a total hip replacement.
What could go wrong: This is a post-approval study, not a new breakthrough. The device has known risks like metal wear, implant loosening, or need for revision surgery. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

arthritic joint disease osteoarthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARTHRITIS

Contacts and locations

Locations

Anderson Orthopaedic Clinic

Alexandria, Virginia, 22306, United States
Aurora Medical Center

Grafton, Wisconsin, 53024, United States
Center for Orthopaedics

Lake Charles, Louisiana, 70601, United States
Hospital for Special Surgery

New York, New York, 10021, United States
OrthoCarolina

Charlotte, North Carolina, 28207, United States
Tucson Orthopaedic Institute

Tucson, Arizona, 85713, United States
University of Rochester Medical Center

Rochester, New York, 14672, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.